((('male gender'[Title/Abstract] OR 'female gender'[Title/Abstract] OR 'male sex'[Title/Abstract] OR 'female sex'[Title/Abstract]) AND calcification[Title/Abstract] AND ('fibroblast growth factor-23'[Title/Abstract] OR FGF-23[Title/Abstract] OR FGF23[Title/Abstract] OR Klotho[Title/Abstract] OR Osteopontin[Title/Abstract] OR Osteoprotegerin[Title/Abstract] OR Osteocalcin[Title/Abstract] OR 'parathyroid hormone'[Title/Abstract] OR 'fetuin-A'[Title/Abstract] OR 'fetuin A'[Title/Abstract] OR 'matrix Gla-protein'[Title/Abstract] OR MGP OR 'alkaline phosphatase'[Title/Abstract] OR microRNAs[Title/Abstract])) AND ('chronic kidney disease’[Title/Abstract] OR 'chronic renal disease'[Title/Abstract] OR 'chronic renal insufficiency’[Title/Abstract] OR 'kidney transplant'[Title/Abstract] OR 'renal transplant'[Title/Abstract] OR ‘end-stage kidney disease’[Title/Abstract] OR 'end-stage renal disease'[Title/Abstract] OR 'dialysis'[Title/Abstract])) NOT review[Publication Type]

1: Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum
phosphorus and calcium x phosphate product with mortality risk in chronic
hemodialysis patients: a national study. Am J Kidney Dis. 1998 Apr;31(4):607-17.
doi: 10.1053/ajkd.1998.v31.pm9531176. PMID: 9531176.

2: Lioufas NM, Pedagogos E, Hawley CM, Pascoe EM, Elder GJ, Badve SV, Valks A,
Toussaint ND; on behalf of the IMPROVE-CKD Investigators. Aortic Calcification
and Arterial Stiffness Burden in a Chronic Kidney Disease Cohort with High
Cardiovascular Risk: Baseline Characteristics of the Impact of Phosphate
Reduction On Vascular End-Points in Chronic Kidney Disease Trial. Am J Nephrol.
2020;51(3):201-215. doi: 10.1159/000505717. Epub 2020 Feb 5. PMID: 32023606.

3: Ho TY, Chen NC, Hsu CY, Huang CW, Lee PT, Chou KJ, Fang HC, Chen CL.
Evaluation of the association of Wnt signaling with coronary artery
calcification in patients on dialysis with severe secondary hyperparathyroidism.
BMC Nephrol. 2019 Sep 2;20(1):345. doi: 10.1186/s12882-019-1543-3. PMID:
31477034; PMCID: PMC6721332.

4: Kuo TH, Lin WH, Chao JY, Wu AB, Tseng CC, Chang YT, Liou HH, Wang MC. Serum
sclerostin levels are positively related to bone mineral density in peritoneal
dialysis patients: a cross-sectional study. BMC Nephrol. 2019 Jul 17;20(1):266.
doi: 10.1186/s12882-019-1452-5. PMID: 31315601; PMCID: PMC6637583.

5: Hou JS, Lin YL, Wang CH, Lai YH, Kuo CH, Subeq YM, Hsu BG. Serum
osteoprotegerin is an independent marker of central arterial stiffness as
assessed using carotid-femoral pulse wave velocity in hemodialysis patients: a
cross sectional study. BMC Nephrol. 2019 May 23;20(1):184. doi:
10.1186/s12882-019-1374-2. PMID: 31122190; PMCID: PMC6533647.

6: Beddhu S, Baird B, Ma X, Cheung AK, Greene T. Serum alkaline phosphatase and
mortality in hemodialysis patients. Clin Nephrol. 2010 Aug;74(2):91-6. doi:
10.5414/cnp74091. PMID: 20630128.

7: Nishizawa Y, Jono S, Ishimura E, Shioi A. Hyperphosphatemia and vascular
calcification in end-stage renal disease. J Ren Nutr. 2005 Jan;15(1):178-82.
doi: 10.1053/j.jrn.2004.09.027. PMID: 15648030.

8: Okamoto T, Hatakeyama S, Kodama H, Horiguchi H, Kubota Y, Kido K, Momota M,
Hosogoe S, Tanaka Y, Takashima T, Saitoh F, Suzuki T, Ohyama C. The relationship
between poor nutritional status and progression of aortic calcification in
patients on maintenance hemodialysis. BMC Nephrol. 2018 Mar 20;19(1):71. doi:
10.1186/s12882-018-0872-y. PMID: 29558928; PMCID: PMC5861641.

9: Hayashi M, Takamatsu I, Kanno Y, Yoshida T, Abe T, Sato Y; Japanese
Calciphylaxis Study Group. A case-control study of calciphylaxis in Japanese
end-stage renal disease patients. Nephrol Dial Transplant. 2012
Apr;27(4):1580-4. doi: 10.1093/ndt/gfr658. Epub 2011 Nov 25. PMID: 22121234.

10: Claes KJ, Viaene L, Heye S, Meijers B, d'Haese P, Evenepoel P. Sclerostin:
Another vascular calcification inhibitor? J Clin Endocrinol Metab. 2013
Aug;98(8):3221-8. doi: 10.1210/jc.2013-1521. Epub 2013 Jun 20. PMID: 23788689.

11: Tamei N, Ogawa T, Ishida H, Ando Y, Nitta K. Serum fibroblast growth
factor-23 levels and progression of aortic arch calcification in non-diabetic
patients on chronic hemodialysis. J Atheroscler Thromb. 2011;18(3):217-23. doi:
10.5551/jat.5595. Epub 2010 Dec 1. PMID: 21139318.

12: Baralić M, Brković V, Stojanov V, Stanković S, Lalić N, Đurić P, Đukanović
L, Kašiković M, Petrović M, Petrović M, Stošović M, Ležaić V. Dual Roles of the
Mineral Metabolism Disorders Biomarkers in Prevalent Hemodilysis Patients: In
Renal Bone Disease and in Vascular Calcification. J Med Biochem. 2019 Mar
3;38(2):134-144. doi: 10.2478/jomb-2018-0026. PMID: 30867641; PMCID: PMC6411002.

13: Rivet J, Lebbé C, Urena P, Cordoliani F, Martinez F, Baglin AC, Aubert P,
Aractingi S, Ronco P, Fournier P, Janin A. Cutaneous calcification in patients
with end-stage renal disease: a regulated process associated with in situ
osteopontin expression. Arch Dermatol. 2006 Jul;142(7):900-6. doi:
10.1001/archderm.142.7.900. PMID: 16847207.

14: Chiu YW, Adler SG, Budoff MJ, Takasu J, Ashai J, Mehrotra R. Coronary artery
calcification and mortality in diabetic patients with proteinuria. Kidney Int.
2010 Jun;77(12):1107-14. doi: 10.1038/ki.2010.70. Epub 2010 Mar 17. PMID:
20237457.

15: Qureshi AR, Olauson H, Witasp A, Haarhaus M, Brandenburg V, Wernerson A,
Lindholm B, Söderberg M, Wennberg L, Nordfors L, Ripsweden J, Barany P,
Stenvinkel P. Increased circulating sclerostin levels in end-stage renal disease
predict biopsy-verified vascular medial calcification and coronary artery
calcification. Kidney Int. 2015 Dec;88(6):1356-1364. doi: 10.1038/ki.2015.194.
Epub 2015 Sep 2. PMID: 26331407.

16: Porter CJ, Stavroulopoulos A, Roe SD, Pointon K, Cassidy MJ. Detection of
coronary and peripheral artery calcification in patients with chronic kidney
disease stages 3 and 4, with and without diabetes. Nephrol Dial Transplant. 2007
Nov;22(11):3208-13. doi: 10.1093/ndt/gfm377. Epub 2007 Jul 7. PMID: 17617653.

17: Gonçalves FL, Elias RM, dos Reis LM, Graciolli FG, Zampieri FG, Oliveira RB,
Jorgetti V, Moysés RM. Serum sclerostin is an independent predictor of mortality
in hemodialysis patients. BMC Nephrol. 2014 Dec 2;15:190. doi:
10.1186/1471-2369-15-190. PMID: 25465028; PMCID: PMC4265422.

18: Kanbay M, Wolf M, Selcoki Y, Solak Y, Ikizek M, Uysal S, Segall L, Armutcu
F, Eryonucu B, Duranay M, Goldsmith D, Covic A. Association of serum calcitonin
with coronary artery disease in individuals with and without chronic kidney
disease. Int Urol Nephrol. 2012 Aug;44(4):1169-75. doi:
10.1007/s11255-011-0076-x. Epub 2011 Dec 1. PMID: 22130958.

19: Scialla JJ, Leonard MB, Townsend RR, Appel L, Wolf M, Budoff MJ, Chen J,
Lustigova E, Gadegbeku CA, Glenn M, Hanish A, Raj D, Rosas SE, Seliger SL, Weir
MR, Parekh RS; CRIC Study Group. Correlates of osteoprotegerin and association
with aortic pulse wave velocity in patients with chronic kidney disease. Clin J
Am Soc Nephrol. 2011 Nov;6(11):2612-9. doi: 10.2215/CJN.03910411. Epub 2011 Sep
22. PMID: 21940840; PMCID: PMC3206002.

20: Sumida Y, Nakayama M, Nagata M, Nakashita S, Suehiro T, Kaizu Y, Ikeda H,
Izumaru K. Carotid artery calcification and atherosclerosis at the initiation of
hemodialysis in patients with end-stage renal disease. Clin Nephrol. 2010
May;73(5):360-9. doi: 10.5414/cnp73360. PMID: 20420796.

21: Jean G, Bresson E, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot
C. Peripheral vascular calcification in long-haemodialysis patients: associated
factors and survival consequences. Nephrol Dial Transplant. 2009
Mar;24(3):948-55. doi: 10.1093/ndt/gfn571. Epub 2008 Oct 13. PMID: 18852190.

22: Sigrist MK, Levin A, Er L, McIntyre CW. Elevated osteoprotegerin is
associated with all-cause mortality in CKD stage 4 and 5 patients in addition to
vascular calcification. Nephrol Dial Transplant. 2009 Oct;24(10):3157-62. doi:
10.1093/ndt/gfp253. Epub 2009 Jun 2. PMID: 19491380.

23: Schlieper G, Brandenburg V, Djuric Z, Damjanovic T, Markovic N, Schurgers L,
Kruger T, Westenfeld R, Ackermann D, Haselhuhn A, Dimkovic S, Ketteler M, Floege
J, Dimkovic N. Risk factors for cardiovascular calcifications in non-diabetic
Caucasian haemodialysis patients. Kidney Blood Press Res. 2009;32(3):161-8. doi:
10.1159/000221064. Epub 2009 May 26. PMID: 19468238.

24: Sigrist MK, Taal MW, Bungay P, McIntyre CW. Progressive vascular
calcification over 2 years is associated with arterial stiffening and increased
mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc
Nephrol. 2007 Nov;2(6):1241-8. doi: 10.2215/CJN.02190507. Epub 2007 Oct 10.
PMID: 17928470.

25: Craver L, Dusso A, Martinez-Alonso M, Sarro F, Valdivielso JM, Fernández E.
A low fractional excretion of Phosphate/Fgf23 ratio is associated with severe
abdominal Aortic calcification in stage 3 and 4 kidney disease patients. BMC
Nephrol. 2013 Oct 12;14:221. doi: 10.1186/1471-2369-14-221. PMID: 24119158;
PMCID: PMC3852798.

26: Jean G, Charra B, Chazot C. Vitamin D deficiency and associated factors in
hemodialysis patients. J Ren Nutr. 2008 Sep;18(5):395-9. doi:
10.1053/j.jrn.2008.04.003. PMID: 18721733.

27: Di Iorio BR, Bortone S, Piscopo C, Grimaldi P, Cucciniello E, D'Avanzo E,
Mondillo F, Cillo N, Bellizzi V. Cardiac vascular calcification and QT interval
in ESRD patients: is there a link? Blood Purif. 2006;24(5-6):451-9. doi:
10.1159/000095362. Epub 2006 Aug 25. PMID: 16940716.

28: Mazzaferro S, Pasquali M, Pugliese F, Barresi G, Carbone I, Francone M,
Sardella D, Taggi F. Serum levels of calcification inhibition proteins and
coronary artery calcium score: comparison between transplantation and dialysis.
Am J Nephrol. 2007;27(1):75-83. doi: 10.1159/000099095. Epub 2007 Jan 26. PMID:
17259697.

29: Huang JW, Lien YC, Yang CY, Liu KL, Fang CC, Wu CK, Lee JK, Wu HY, Chiang
CK, Cheng HT, Yen CJ, Hung KY. High peritoneal KT/V and peritonitis rates are
associated with peritoneal calcification. PLoS One. 2013 Aug 19;8(8):e71636.
doi: 10.1371/journal.pone.0071636. PMID: 23977097; PMCID: PMC3747216.

30: Fusaro M, Gallieni M, Noale M, Tripepi G, Miozzo D, Plebani M, Zaninotto M,
Guglielmi G, Miotto D, Fabris F, Piccoli A, Vilei MT, Sella S, Morachiello P,
Stoppa F, Rossini M, Giannini S. The relationship between the Spine Deformity
Index, biochemical parameters of bone metabolism and vascular calcifications:
results from the Epidemiological VERtebral FRACtures iTalian Study (EVERFRACT)
in dialysis patients. Clin Chem Lab Med. 2014 Nov;52(11):1595-603. doi:
10.1515/cclm-2014-0194. PMID: 24897402.
